
It is important to use correct organization and appropriate methods for demonstrating biosimilar comparability to support regulatory filings.
Thomas A. Little, PhD, is president, Thomas A. Little Consulting and BioAssay Sciences, 12401 North Wildflower Lane, Highland, Utah 84003, USA, drlittle@dr-tom.com.

It is important to use correct organization and appropriate methods for demonstrating biosimilar comparability to support regulatory filings.

Bioassays are critical for determining drug substance and drug product potency, which is why it is important to understand the fundamentals of developing an effective bioassay.

Published: August 31st 2021 | Updated:

Published: December 4th 2019 | Updated: